Not exact matches
«I'm working with Professor Richard Oreffo and Dr Rahul Tare
from the University's Centre for Human Development,
Stem Cells and Regeneration who are trying to create and grow cartilage in the lab using a patients» own (autologous) stem cells to then be implanted back into the patient if they have a cartilage defect,» she expla
Stem Cells and Regeneration who are trying to create and grow cartilage in the lab using a patients» own (autologous) stem cells to then be implanted back into the patient if they have a cartilage defect,» she expl
Cells and Regeneration who are trying to create and grow cartilage in the lab using a patients» own (
autologous)
stem cells to then be implanted back into the patient if they have a cartilage defect,» she expla
stem cells to then be implanted back into the patient if they have a cartilage defect,» she expl
cells to then be implanted back into the patient if they have a cartilage defect,» she explains.
Results
from a clinical trial investigating a new T
cell receptor (TCR) therapy that uses a person's own immune system to recognize and destroy cancer
cells demonstrated a clinical response in 80 percent of multiple myeloma patients with advanced disease after undergoing
autologous stem cell transplants (ASCT).
The treatments typically use
autologous stem cells (those obtained
from one's body) to treat everything
from bad knees to incurable disease such as ALS or Parkinson's.
Our platform includes two distinct approaches to create these vaccines: AST - VAC1, an
autologous (patient - specific) vaccine based on
cells sourced
from the patient, and AST - VAC2, an allogeneic (non-patient specific) vaccine manufactured
from our proprietary pluripotent
stem cell platform.
Review of «Biological markers of Mesenchymal Stromal
Cells as Predictors of response to
Autologous Stem Cell Transplantation in Patients with Amyotrophic Lateral Sclerosis; an Investigator - Initiated Trial and in Vivo Study»
from Stem Cells by Stuart P. Atkinson
His current focus is on the production of
autologous hepatocytes
from patient - derived induced pluripotent
stem cells (iPSCs).
The therapy
from Trinity Clinic Fukuoka involves 10 intravenously administered doses of 200 million
autologous adipose tissue - derived mesenchymal
stem cells.
For example, clinics may offer
autologous (
from your own body)
stem cell treatments, which may not be subject to oversight if the
cells are minimally manipulated.
Patients receive one of two types of
stem cell - based transplants:
autologous, in which a patient donates and receives back his / her own
stem cells; or allogeneic, in which bone marrow - derived
stem cells come
from a related or unrelated donor whose human leukocyte antigens (HLA) are genetically matched with those of a patient.
The Treatment:
Autologous hematopoietic
stem cell transplantation (AHSCT) is an aggressive procedure which involves collecting
stem cells from an...
Our expertise includes both
autologous and allogeneic
stem cell transplants (using
cells directly
from the patient and
from another person, respectively), using
cells derived
from bone marrow, peripheral blood and cord blood.
The technique involves replacing a mutated copy of the gene with a healthy copy in
stem cells isolated
from the patient, which are then transfused back into the body — a process known as
autologous stem cell transplantation.
No, we use
autologous (
from self) adult
stem cells derived
from your own body fat.
Unmatched performance — high transfection efficiency &
cell viability in primary cells Fully scalable — from R&D to the clinic without reoptimization Safe — non-viral cell engineering in closed, sterile, computer - controlled environment Cell loading flexibility — mRNA, gRNA, siRNA, DNA, proteins, cell lysates, and small molecules into autologous or allogenic immune, stem / progenitor, or somatic cells Regulatory ease — Master File designation with the CBER Division of the U.S. FDA, cleared by NIH's RAC and Health Canada, cGMP - compliant, and CE - ma
cell viability in primary
cells Fully scalable —
from R&D to the clinic without reoptimization Safe — non-viral
cell engineering in closed, sterile, computer - controlled environment Cell loading flexibility — mRNA, gRNA, siRNA, DNA, proteins, cell lysates, and small molecules into autologous or allogenic immune, stem / progenitor, or somatic cells Regulatory ease — Master File designation with the CBER Division of the U.S. FDA, cleared by NIH's RAC and Health Canada, cGMP - compliant, and CE - ma
cell engineering in closed, sterile, computer - controlled environment
Cell loading flexibility — mRNA, gRNA, siRNA, DNA, proteins, cell lysates, and small molecules into autologous or allogenic immune, stem / progenitor, or somatic cells Regulatory ease — Master File designation with the CBER Division of the U.S. FDA, cleared by NIH's RAC and Health Canada, cGMP - compliant, and CE - ma
Cell loading flexibility — mRNA, gRNA, siRNA, DNA, proteins,
cell lysates, and small molecules into autologous or allogenic immune, stem / progenitor, or somatic cells Regulatory ease — Master File designation with the CBER Division of the U.S. FDA, cleared by NIH's RAC and Health Canada, cGMP - compliant, and CE - ma
cell lysates, and small molecules into
autologous or allogenic immune,
stem / progenitor, or somatic
cells Regulatory ease — Master File designation with the CBER Division of the U.S. FDA, cleared by NIH's RAC and Health Canada, cGMP - compliant, and CE - marked
It is an
autologous limbal
stem cell composite graft, prepared
from the limbal biopsy excised
from the healthy eye of the patient.
One type of
stem cell transplant,
autologous hematopoietic
stem cell transplantation, uses
stems cells from your own bone marrow, or
from external umbilical cord blood.
MediVet's
Stem Cell therapy allows our veterinarians to isolate stem cells from your pet's own (autologous) fat tissue, wake them up and reintroduce them directly into damaged ar
Stem Cell therapy allows our veterinarians to isolate
stem cells from your pet's own (autologous) fat tissue, wake them up and reintroduce them directly into damaged ar
stem cells from your pet's own (
autologous) fat tissue, wake them up and reintroduce them directly into damaged areas.
This is called
Autologous Therapy when the
stem cells come
from your own body's tissues.
We use
autologous fat derived
stem cells (also called adult
stem cells, mesenchymal
stem cells, stromal vascular fraction
stem cells...) which are
from the pet itself so there is little likelihood of any untoward reaction.
After experiencing how
autologous adult
stem cell therapy helped a loved one struggling with Multiple Sclerosis regain their life quality, Stemedix was founded with the determination to help offer this alternative therapy to others around the world suffering
from debilitating diseases.